Thirani Projects (538464)
Asset PlayScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹3.47 |
| Market Cap | ₹7.01 Cr |
| P/E Ratio | 9.12 |
| ROCE | 3.48% |
| ROE | 7.81% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹3.42 — ₹7.4 |
| Sector | Finance |
| Book Value | ₹5.93 |
Strengths
- Trading at ₹3.47 versus book value ₹5.93, a 41% discount to book (P/B 0.59)
- Piotroski F-Score of 7/9 suggests balance sheet and operating signals are not severely deteriorating
- Reported P/E of 9.12 is statistically low if trailing earnings are genuine
- At near the 52-week low of ₹3.42, much of the bad news appears priced in
Concerns
- Latest quarter shows zero sales and zero net profit — no active earning engine
- Zero sales growth, zero profit growth, and zero dividend provide no return momentum
- ROCE of 3.48% is very weak for an NBFC; ROE of 7.81% is mediocre
- Promoter holding is not disclosed and debt/equity is stated as N/A, creating transparency risk
AI Analysis
At ₹3.47, this ₹7 crore NBFC trades at 0.59 times book value of ₹5.93. On the surface, that looks like a classic Graham bargain — a 41% discount to what the balance sheet says. But I must ask: what is this company actually earning? The latest quarter shows sales of ₹0 and net profit of ₹0. Growth is exactly zero, and there is no dividend. A financial company with no current income is not a business; it is a shell holding assets. The reported ROE of 7.81% and ROCE of 3.48% are thin, and 3.48% return on capital is far below what I need from a lender. The Piotroski F-score of 7/9 gives some comfort on financial health, but a score cannot replace earning power. The P/E of 9.12 looks low, yet with zero latest-quarter profits, that multiple may rest on stale or non-recurring earnings. The PEG of 0.32 is meaningless when growth is stated as zero. I also see no promoter holding details and no debt-to-equity data — too many critical blanks for such a small company. This is not a wonderful business at any price. It is, at best, an asset play: buy cheap against book value and hope management unlocks value through sale, liquidation, or restructuring. But in small caps, book value can deteriorate quickly if loans sour or assets are overstated. A margin of safety must come from tangible net assets, not just reported numbers. I would demand the full annual report, check every loan on the books, and understand why operations have gone quiet. Without that, this is a statistical curiosity, not a confident investment.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer